Insulin Icodec

  • Favorite
Chongqing Peg-Bio Biopharm Co., Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

8/10

Product Information

  • Active Ingredients:Pichia pastoria
  • Molecular Weight:6380.38±1.0Da
  • Pharmacopeia:USP
  • Package Type:Bag
  • Shelf Life:2 years
  • Storage:-20℃
  • Place of Origin:CHINA

Description

1 Product Details

Chinese name:Insulin Icodec   English name:Insulin Icodec

CAS:1188379-43-2                   Brand:Peg-Bio

Place of Origin:Chongqing      Storage Condition:-20°C

Purity:>98%                              Product Category:Insulin Icodec

Alias:Icoglucagon                     Origin/Manufacturer:Chongqing Paijin Biotechnology Co. ,Ltd

Character:Dry powder


Paijin Bio also adopts the recombinant expression technology of genetic engineering, using Brettanomyces cerevisiae as the recombinant expression host bacterium, and prepares Icodec API through the process steps of fermentation and cultivation, inducing the expression of precursors, solid-liquid separation, enzymolysis, fatty acid modification, purification, and drying, etc., which has the competitive advantages of high quality and low cost.


quality standard

                                        Test Items
Standard designation
NatureappearanceShould be a white or off-white powder


Key Quality Indicators



molecular mass6380.38±1.0Da
purityNot less than 98%
polymer protein< 1.0%
protein contentShould be 80%-100%


Routine Testing Program

dry weight loss< 10.0%
Host protein residues<100ng/m
DNA residue<10ng/7.7mg
microbial limit<100cfu/g


3  Advantages of cooperating with Peg-Bio Biopharm

(1) Paijin Biologicals has completed the development of kilograms of high-quality Icodec API 

technology, which can meet the partner's needs for the development of small- and pilot-scale

 compound formulations;

(2) Paigeon has completed the development of Icodec single preparation and IcoSema 

compound preparation, and can provide one-stop technology development services, including

 but not limited to: compound preparation prescription development, compound preparation 

process development, compound preparation testing method development, compound 

preparation in vivo efficacy evaluation;

(3) Paijin Icodec is in the process of declaring its DMF in the U.S.A., which is convenient for the

 partner to declare its foreign registrations.


You Might Also Like
Change a group
Inquiry Cart(0)